FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a compound of the following formula
or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The invention also relates to a pharmaceutical composition with hepatoprotective activity based on the said compound.
EFFECT: obtaining a new compound that can be used in medicine as an effective hepatoprotective agent.
3 cl, 9 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW HEPATOPROTECTIVE AGENTS AND METHODS FOR PREPARING THEM | 2023 |
|
RU2815370C1 |
| APPLICATION OF A TRICYCLIC SULPHUR-CONTAINING DERIVATIVE OF 1,2-DIHYDROQUINOLINE FOR INHIBITING THE REPLICATION OF BETACORONAVIRUSES, INCLUDING SARS-COV-2 | 2021 |
|
RU2780247C1 |
| PHARMACEUTICAL COMPOSITION, INCLUDING TRICYCLIC SULFUR-CONTAINING 1,2-DIHYDROQUINOLINE DERIVATIVE FOR INHIBITION OF REPLICATION OF BETA CORONAVIRUSES, INCLUDING SARS-CoV-2, AND METHOD OF ITS USE | 2021 |
|
RU2814434C1 |
| METHOD OF PRODUCING A TRICYCLIC SULFUR-CONTAINING DERIVATIVE OF 1,2-DIHYDROQUINOLINE FOR INHIBITING REPLICATION OF BETA-CORONAVIRUSES, INCLUDING SARS-CoV-2 | 2021 |
|
RU2819783C1 |
| HYDROSULFIDE DERIVATIVES OF NON-STEROID ANTI-INFLAMMATORY DRUGS | 2007 |
|
RU2468019C2 |
| 4- OR 5-AMINOSALICYLIC ACID DERIVATIVES | 2006 |
|
RU2414476C2 |
| STRUCTURALLY ENHANCED OXYGEN-CONTAINING FATTY ACIDS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS | 2018 |
|
RU2820995C2 |
| COMPOUND (6-{[(1S)-1(5-FLUORO-4-OXO-3-PHENYL-3,4-DIHYDROQUINAZOLIN-2-YL)PROPYL]AMINO}-9H-PURIN-9-YL)METHYL ACETATE AS INHIBITOR OF P110δ- DELTA ISOFORM OF PHOSPHOINOSITIDE-3-KINASE (PI3K), METHODS FOR ITS PRODUCTION (OPTIONS) AND APPLICATIONS | 2018 |
|
RU2675237C1 |
| METHOD OF OBTAINING HYDROXAMIC ACIDS, DERIVATIVES OF 2-ARYL-2.3-DIHYDROQUINAZOLIN-4(1H)-ONES | 2020 |
|
RU2744750C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING 1,2-DITHIOL-THIONE DERIVATIVE FOR PREVENTING OR TREATING DISEASES MEDIATED BY HIGH LXR-ALPHA EXPRESSION | 2009 |
|
RU2491065C2 |
